0001209191-18-022581.txt : 20180402 0001209191-18-022581.hdr.sgml : 20180402 20180402184621 ACCESSION NUMBER: 0001209191-18-022581 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180401 FILED AS OF DATE: 20180402 DATE AS OF CHANGE: 20180402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kewalramani Reshma CENTRAL INDEX KEY: 0001735944 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 18730788 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS, INC. STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 3/A 1 doc3a.xml FORM 3/A SUBMISSION X0206 3/A 2018-04-01 2018-04-01 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001735944 Kewalramani Reshma C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP and CMO Common Stock 4214 D Stock Option (Right to Buy) 155.57 2028-02-05 Common Stock 8153 D Includes a restricted stock unit award for 1,909 shares that vests in two equal installments on 2/17/2019 and 2/17/2020. This Form 3/A is being filed to correct an error in the vesting schedule previously reported in the above footnote. The option vests in 16 quarterly installments from 2/6/2018. /s/ Stephen Migausky, Attorney-in-Fact 2018-04-02